Transactions – BroadOak Capital Partners

Advisory Transactions

Relationship Based. Authentic Partnership. Common Goals.

Sale of the company to Werfen

Acquisition of A4P Bio

Sale of the company to Oncodesign Services

Acquistion of celares GmBH

Sale of the company to Medix Biochemica

Sale of the company to Biosynth Carbosynth

Acquisition of FlowMetric

Aquisition of antibodies-online

Sale of the company to Maravai LifeSciences

Sale of the company to Cytek Biosciences

Sale of the company to Element Materials Technology

Sale of the company to Element Materials Technology

Sale of the company to Vitruvian

Sale of the company to Versiti

Sale of the company to BioLife Solutions

Sale of the company to PerkinElmer

Sale of company to Thompson Street Capital Partners

Sale of the company to LGC Limited

Sale of the company to Thermo Fisher Scientific Inc.

Sale of the company to Unchained Labs

Exclusive placement agent for Labconnect, Inc.

Sale of the company to Takara Bio Inc.

Sale of the company to Thermo Fisher Scientific Inc.

Strategic acquisition of Cygnus

Strategic acquisition of TriLink Biotechnologies

Sale of the company to PerkinElmer

Clarity Medical Systems has sold its RetCam Ophthalmic Imaging System business to Natus Medical

Sale of the company to Lab Corporation of America

Strategic equity investment in Vector Laboratories

Sale of the company to OpGen, Inc.

Sale of the iPS Cell Business Unit of Stemgent ReproCELL, Inc.

Sale of miRInform Thyroid and Pancrease Test to PDI Inc. (now Interpace Diagnostics)

Sale of company to StoneCalibre

Equity investment and strategic collaboration with Brooks Automation, Inc.

Sale of in-vivo preclinical services business to BIOQUAL, Inc.

Sale of sequencing services business to BioReference Laboratories, Inc.

Sale of the Life Science business of SDIX to OriGene Technologies, Inc.

Sale of UVP LLC to Analytik Jena AG

Sale of BioServices business to Precision Bioservices

Sale of Food Safety and GMO businesses
to Romer Labs

Sale of preclinical in-vivo imaging business to Bruker

Exclusive placement agent for OpGen, Inc.

BroadOak Partners provided financial advisory
services to Quanta Biosciences

Non-exclusive license agreement with QIAGEN

BroadOak retained to provide ongoing financial
advisory services

SVT gains exclusive rights in China to ENMD-2076 through investment in EntreMed, Inc.

Replacement and expansion of Cayman Chemical Company’s debt facilities

Acquisition of Hyaluron, Inc.

Acquisition of GlobalStem, Inc.

Sale of in-vivo preclinical CRO services business to
Taconic Farms, Inc.

Sale of Alpha Innotech Corp. to Cell Biosciences, Inc.

Collaboration and license agreement with Novartis

Sale of non-core assets to Intrexon Corporation

Sale of Assay Designs, Inc. to Enzo Biochem, Inc.

Sale of Semrock Inc. to IDEX Corp

Sale of Fluorescent Detection Products Business

Acquisition of biodefense vaccines business from
Avecia Biologics Limited

Sale of In Vitro Technologies, Inc to Celsis International Plc

Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory

Acquisition of Control Delivery Systems

Sale of NovaScreen Biosciences to Caliper Life Sciences

Merger with xantra

Code for Load More button – Do Not Delete

Partner with BroadOak

Investing

Advisory

About

Portfolio

Transactions

News

Contact

Team

Investor Login

Join our newsletter.

Sign up to stay informed about our work.

2022 © BroadOak Capital Partners, LLC.
All rights reserved.

Member FINRA | SIPC
Business Continuity Disclosure
Privacy Policy